Join the club for FREE to access the whole archive and other member benefits.

Susanne Raab

Chief Development Officer at Endogena Therapeutics

Susanne Raab is an accomplished in vivo pharmacology leader in drug discovery and development research. She has a solid track record of successful contributions to the R&D pipeline, advancing projects through development to clinical proof of concept. Susanne has worked at Roche for over 17 years as in vivo pharmacologist as well as project leader in different therapeutic areas. Susanne was in charge of in vivo pharmacology in the ophthalmology group at Roche, whereby she advanced candidates to clinical proof of concept. She was further involved in the planning, leading and managing of outsourcing activities with CROs and academic collaborators worldwide.

Susanne holds a MSc and PhD in Agricultural Biology from the University of Hohenheim in Germany and a Diploma in Medicines Development Sciences. Her main research focus lies on ophthalmological, cardiovascular and metabolic diseases.

Visit website: https://endogena.com/#people/#susanne

 susanne-raab-07a106124

See also: Company Endogena Therapeutics - Clinical-stage biotech company focussed on endogenous regenerative medicines

Details last updated 26-Aug-2022

Susanne Raab is also referenced in the following:

Endogena Therapeutics

Clinical-stage biotech company focussed on endogenous regenerative medicines